diquafosol has been researched along with 5-bromouridine triphosphate in 2 studies
| Studies (diquafosol) | Trials (diquafosol) | Recent Studies (post-2010) (diquafosol) | Studies (5-bromouridine triphosphate) | Trials (5-bromouridine triphosphate) | Recent Studies (post-2010) (5-bromouridine triphosphate) |
|---|---|---|---|---|---|
| 126 | 38 | 92 | 53 | 0 | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besada, P; Calenbergh, SV; Costanzi, S; Cosyn, L; Fricks, I; Harden, TK; Ivanov, AA; Jacobson, KA; Ko, H; Maddileti, S | 1 |
| Fischer, B; Ginsburg-Shmuel, T; Haas, M; Kalid, O; Reiser, G; Schumann, M; Stern, N | 1 |
2 other study(ies) available for diquafosol and 5-bromouridine triphosphate
| Article | Year |
|---|---|
Molecular modeling of the human P2Y2 receptor and design of a selective agonist, 2'-amino-2'-deoxy-2-thiouridine 5'-triphosphate.
Topics: Adenosine Triphosphate; Binding Sites; Cell Line, Tumor; Drug Design; Humans; Models, Molecular; Monte Carlo Method; Protein Conformation; Purinergic P2 Receptor Agonists; Quantitative Structure-Activity Relationship; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Uridine Triphosphate | 2007 |
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.
Topics: Calcium; Cell Line, Tumor; Humans; Ligands; Magnetic Resonance Spectroscopy; Molecular Conformation; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Structure-Activity Relationship; Transfection; Uridine Diphosphate | 2010 |